Shares of consumer healthcare co Kenvue (KVUE.N) fall 10% to $18.46
U.S. Health Secretary Robert F. Kennedy Jr. plans to release government report linking Tylenol use during pregnancy to autism, The Wall Street Journal reports, citing people familiar with matter
Tylenol, whose active ingredient is acetaminophen, is made by Kenvue and is widely used for pain relief, including by pregnant women
Report will also suggest medicine derived from folate, called folinic acid, can be used to treat symptoms of the disorder in some people, WSJ adds
Speaking on WSJ report, Kenvue says it continues to believe there is no causal link between acetaminophen use during pregnancy and autism, CNBC reports
Including session’s moves, stock down 12% YTD

KVUE

Shares of Kenvuefell 10% to $18.46 following a report that Health Secretary Robert F. Kennedy Jr. will release a government report linking Tylenol use during pregnancy to autism. Kenvue, which produces Tylenol, maintains that there is no causal link between acetaminophen use and autism. The stock is down 12% year-to-date.

BUZZ-Kenvue tumbles after report RFK Jr. links autism risk in tylenol use